Mark Adamchak - 01 Oct 2024 Form 4 Insider Report for Bionano Genomics, Inc. (BNGO)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BNGO	Stock Option (Right to Buy)	Award	$0	+17,500		$0.000000	17,500	01 Oct 2024	Common Stock	17,500	$0.4200	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	100% of the shares subject to the option vest on the one-year anniversary of the grant date.